Evidence map›Paper›PMID 40403985›Full record

ArticleGastroenterology2025

Reply.

Mimi C Tan, Rebecca R Richards-Kortum, Sharmila Anandasabapathy

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mimi C TanSection of Gastroenterology and Hepatology, Department of Medicine, Houston, Texas; Global Programs, Baylor College of Medicine, Houston, Texas.
Rebecca R Richards-KortumDepartment of Bioengineering, Rice University, Houston, Texas.
Sharmila AnandasabapathySection of Gastroenterology and Hepatology, Department of Medicine, Houston, Texas; Global Programs, Baylor College of Medicine, Houston, Texas.

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
High Resolution Microendoscopy for the Management of Esophageal NeoplasiaR01CA181275 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Sharmila Anandasabapathy, Amy L McGuire · 2014 to 2026
$6.3M
Development and Validation of an Automated Algorithm for Real-time Detection of Neoplasia in Barrett's Esophagus using a Low-cost, Portable MicroendoscopeK23DK129776 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Mimi Chang Tan · 2022 to 2026
$993k
NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA181275NIDDK NIH HHS K23 DK129776
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40403985
PMCPMC12699990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.